Quarterly Review

Tuesday August 11, 2026

Finally getting around to this. I pulled the biotechs that have already released earnings and made a watchlist. I am going to go through each of these trying to find the best stocks (as I see it) in these very uncertain market conditions.

A caveat. The comparative analysis is from a local Agent I coded. Verify. Verify. Verify.

These are my ratings for my risk appetite. And these ratings are not based on viability of the drug. This is just based on the market setup.

You maybe more familiar with one of these than I am. I am doing this as a digest as fast as possible so I might (and will) miss somethings.

I run a multi-strategy office all by myself so I go fast.

If you want to really get an understanding for how much time you have to put in to confidently run a large account (or if you are considering starting a hedge fund) this is only 1/8th of the stocks listed. Which is only 1/5th of biotechs in the US market.

I will do more tomorrow.